Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 5, 2007, Pages 1143-1149

  Thielmann, Matthias ^a   Neuhäuser, Markus ^a   Marr, Anja ^a   Jaeger, Beate R ^a   Wendt, Daniel ^a   Schuetze, Bernd ^a   Kamler, Markus ^a   Massoudy, Parwis ^a   Erbel, Raimund ^a   Jakob, Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CERIVASTATIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NITRIC ACID DERIVATIVE; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL MORTALITY;

AGED; ANTILIPEMIC AGENTS; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 35448929398     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.07.029     Document Type: Article

References (25)

1. Cholesterol Treatment Trialists. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
2. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 (1995) 1301-1308
3. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
4. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45 (2005) 336-342
5. Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975
6. Pan W., Pintar T., Anton J., et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 (2004) II45-II49
7. Clark L.L., Ikonomidis J.S., Crawford J., et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg 131 (2006) 679-685
8. Collard C.D., Body S.C., Shernan S.K., et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132 (2006) 392-400
9. Powell B.D., Bybee K.A., Valeti U., et al. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol 99 (2007) 785-789
10. Thielmann M., Leyh R., Massoudy P., et al. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 114 suppl (2006) I441-I447
11. Thielmann M., Massoudy P., Schmermund A., et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 26 (2005) 2440-2447
12. Brookmeyer R., Liang K., and Linet M. Matched case-control designs and overmatched analyses. Am J Epidemiol 124 (1986) 693-701
13. Neuhäuser M., and Becher H. Improved odds ratio estimation by post hoc stratification of case-control data. Stat Med 16 (1997) 993-1004
14. Stein E.A., Illingworth D.R., Kwiterovich Jr. P.O., et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 281 (1999) 137-144
15. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336 (1997) 153-163
16. Campeau L., Hunninghake D.B., Knatterud G.L., et al. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors: NHLBI Post Coronary Artery Bypass Graft Clinical Trial. Circulation 99 (1999) 3241-3247
17. Lenderink T., Boersma E., Gitt A.K., et al. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes. Eur Heart J 27 (2006) 1799-1804
18. Herrmann J., Lerman A., Baumgart D., et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 106 (2002) 2180-2183
19. Grundy S.M., Cleeman J.I., Merz C.N.B., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110 (2004) 227-239
20. Erbel R., and Heusch G. Brief review: coronary microembolization. J Am Coll Cardiol 36 (2000) 22-24
21. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 26 (2005) 2493-2519
22. Briguori C., Colombo A., Airoldi F., et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J 25 (2004) 1822-1828
23. Chello M., Anselmi A., Spadaccio C., et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 83 (2007) 1374-1380
24. Liakopoulos O.J., Dorge H., Schmitto J.D., et al. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 54 (2006) 250-254
25. Pascual D.A., Arribas J.M., Tornel P.L., et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg 81 (2006) 78-83